Skip to main content
. 2020 Oct 5;12(10):2861. doi: 10.3390/cancers12102861
α-SMA α- smooth muscle actin
BM-MSCs Bone marrow-derived mesenchymal stem cells
CAF Cancer-associated fibroblast
CK cytokeratin
CTC Circulating Tumor Cell
CXCL9 C-X-C Motif Chemokine Ligand 9
CXCL12 C-X-C Motif Chemokine Ligand 12
CXCL12 C-X-C Motif Chemokine Ligand 14
DAPI 4′,6-diamidino-2-phenylindole
ECM Extracellular matrix
EMP Epithelial–mesenchymal plasticity
EMT Epithelial-to-mesenchymal transition
EV Extracellular vesicle
FAK Focal Adhesion Kinase
FAP Fibroblast activation protein
FGF Fibroblast growth factor
FSP Fibroblast specific protein
IL-6 Interleukin 6
LN lymph nodes
LncRNA Long non-coding RNAs
miRNA microRNA
MMP Matrix metalloproteinases
NGS Next generation sequencing
PDGFC Platelet-derived growth factor
PDGFRα platelet-derived growth factor receptor-α
PDGFRβ Platelet-derived growth factor receptor-β
PMN-MDSCs Polymorphonuclear-myeloid-derived suppressor cells
SDF-1 Stromal cell-derived factor 1
SRC SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase
TAMs Tumor-associated macrophages
TGF-β Transforming growth factor-β
TME Tumor microenvironment
VEGF vascular endothelial growth factor
VEGFR1 Vascular endothelial growth factor receptor 1
WBC White blood cell